Member Login
  1. Stocks
    2. /
  2. IMV Inc. (TSX: IMV)
    3. /

TSX:IMV (IMV Inc.)

About IMV

IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • IMV Inc. (TSX: IMV) Latest News

    Stocks for Beginners

    3 Under-$5 TSX Stocks That Could Double in a Year

    | Jitendra Parashar

    Bay Street analysts expect these three under-$5 stocks to more than double within a year. Buy them today to get…

    Read more »

    Investing

    Value Investing: 1 Pharma Stock to Buy in June 2021

    | Nikhil Kumar

    IMV (TSX:IMV)(NASDAQ:IMV) is a biopharmaceutical company that gives patients with hard-to-treat cancers a chance to enjoy a long and healthy…

    Read more »

    Investing

    44% of Canadians Will Get Cancer: This 1 Stock Will Skyrocket!

    | Chen Liu

    IMV Inc. (TSX:IMV)(NASDAQ:IMV) specializes in making immunotherapies more effective, add the stock to your TFSA or RRSP today!

    Read more »

    Dividend Stocks

    Cure Recession Blues With These Red-Hot Healthcare Stocks

    | Victoria Hetherington

    Viemed Healthcare Inc. (TSX:VMD) and one other medical stock could reward Canadian investors with upside, even despite a recession.

    Read more »

    Dividend Stocks

    3 Top Canadian Healthcare Stocks for Growth Investors

    | Victoria Hetherington

    Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and two other healthcare stocks may have flown under the radar of recession-proofing investors.

    Read more »

    Investing

    2 Biotech Stocks at 52-Week Lows: Should You Buy Today?

    | Ambrose O'Callaghan

    IMV Inc. (TSX:IMV)(NASDAQ:IMV) and Fennec Pharmaceuticals Inc. (TSX:FRX)(NASDAQ:FENC) reached 52-week lows over the last week of trading.

    Read more »

    Dividend Stocks

    Casual Investors: 3 Low-Risk, High-Growth Stocks

    | Victoria Hetherington

    Questor Technology Inc. (TSX:QST) and two other stocks look like surprisingly defensive plays on today’s watch list.

    Read more »